M. Hashimoto et al., Protective effect of OK-432 on mice against endotoxemia and infection withPseudomonas aeruginosa and Salmonella enteritidis, MICROB IMMU, 45(6), 2001, pp. 425-432
OK-432 has been used clinically as a biological response modifier for cance
r therapy. We investigated here the protective effects of OK-432 against en
dotoxic shock and infectious death caused by Pseudomonas aeruginosa and Sal
monella enteritidis in mice and proposed a possible mechanism. Pretreatment
of OK-432 reduced the lethality of lipopolysaccharide (LPS)-induced endoto
xic shock in D-(+)galactosamine-sensitized C3H/HeN mice. OK-432 did not aff
ect the TNF alpha production in blood, but it did decrease the susceptibili
ty to TNF alpha. Furthermore, an acceleration of LPS clearance from blood w
as detected. The pretreatment of OK-432 also decreased the lethality of mic
e in bacterial infection caused by P. aeruginosa and S. enteritidis. The ra
pid decrease of the viable bacteria from the circulating blood and in splee
n and liver in mice was observed in a manner similar to LPS clearance, Thes
e findings indicate that the protective effect of OK-432 against the endoto
xemia and bacteremia may depend on an up-regulation of clearance of LPS and
bacteria and the augmented resistance to TNF alpha.